FUNDERMA

FUNDERMA (Fundación Nacional de Dermatología) is a prominent Bolivian non-profit research organization and clinical center specializing in dermatology and neglected tropical diseases. Based in Santa Cruz de la Sierra, the foundation is a key regional partner for international drug development initiatives, most notably the Drugs for Neglected Diseases initiative (DNDi). FUNDERMA conducts extensive clinical research, including Phase 2 through Phase 4 trials, to evaluate and optimize treatments for cutaneous and mucosal leishmaniasis. Its work focuses on improving therapeutic regimens using drugs such as miltefosine, pentamidine, and paromomycin, as well as exploring innovative modalities like thermotherapy. The foundation plays a vital role in providing specialized medical care to underserved populations and advancing global health strategies for tropical skin diseases.